德國Jena Bioscience www.jenabioscience.com
Jena Bioscience由德國馬普所（MPI）的分子生理學(xué)家于1998年共同創(chuàng)辦的生物公司，致力為全球的科研院所、醫(yī)院、制藥企業(yè)以及診斷試劑盒生產(chǎn)企業(yè)提供各類試劑。在結(jié)構(gòu)學(xué)研究方面全面提供晶體篩選試劑盒、優(yōu)化試劑、工具和各類耗材等。 

Jena Bioscience GmbH was founded in 1998 by a team of scientists from the Max-Planck-Institute for Molecular Physiology in Dortmund. 25+ years of academic know how were condensed into the company in order to develop innovative reagents and technologies for the life science market.
Since the start up, the company has evolved into an established global reagent supplier with more than 6500 products on stock and a customer base in 50+ countries. Jena Bioscience serves three major client groups:
Research laboratories at universities, industry, government, hospitals and medical schools 
Pharmaceutical industry in the process from lead discovery through to pre-clinical stages 
Laboratory & diagnostic reagent kit producers and re-sellers 
Our company premises are located in the city of Jena / Germany with a subsidiary in Teltow, in the vicinity of the German capital Berlin.
 

Jena Bioscience’s products include nucleosides, nucleotides and their non-natural analogs, recombinant proteins & protein production systems, reagents for the crystallization of biological macromolecules and tailor-made solutions for molecular biology and biochemistry.
In our chemistry division, we have hundreds of natural and modified nucleotides available on stock. In addition, with our pre-made building blocks and in-house expertise we manufacture even the most exotic nucleotide analog from mg to kg scale.
In the field of recombinant protein production, Jena Bioscience has developed its proprietary LEXSY technology. LEXSY (Leishmania Expression System) is based on a S1-classified unicellular organism that combines easy handling with a full eukaryotic protein folding and modification machinery including mammalian-like glycosylation. LEXSY is primarily used for the expression of proteins that are expressed at low yields or are inactive in the established systems, and expression levels of up to 500 mg/L of culture were achieved.
For the crystallization of biological macromolecules – which is the bottleneck in determining the 3D-structure of most proteins – we offer specialized reagents for crystal screening, crystal optimization and phasing that can reduce the time for obtaining a high resolution protein structure from several years to a few days.
Our specialized reagents are complemented with a large selection of products for any molecular biology & biochemistry laboratory such as kits for Standard PCR and Real-Time PCR, oligonucleotides, cloning enzymes, mutagenesis technologies, and many more...